Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients

This study determined the efficacy and safety of a modified FOLFOX regimen that improved patient convenience without compromising oxaliplatin dose intensity. A total of 62 patients with previously untreated metastatic colorectal cancer were enrolled to receive, entirely as outpatients, 2-weekly cycl...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, D, Mitchell, P, Michael, M, Beale, P, Friedlander, M, Zalcberg, J, White, S, Clarke, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361919/
https://www.ncbi.nlm.nih.gov/pubmed/15756253
http://dx.doi.org/10.1038/sj.bjc.6602426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361919/
https://www.ncbi.nlm.nih.gov/pubmed/15756253
http://dx.doi.org/10.1038/sj.bjc.6602426

Ejemplares similares